A clinician scientist for the long haul is relatively unusual in medicine. The difficulty journal editors have in getting professionals to review papers which may take four or more hours is a fact of modern academic publishing. There is no financial incentive to participate. Professionalism as a subject is part of formal basic medical training in this era. This has replaced some of the clinical clerkship and apprenticeship time periods of pre-modern medical training. During my undergraduate period in UCD 1968-1974, 'The Clinical Apprentice' and 'A Primer of Medicine' were the prototype general textbooks for medical students of that era [1, 2] . The transformation in learning methods and evaluations can be gauged by my recent review [3] . Academically, he is a Health Research Board of Ireland Clinician Scientist. In the last 10 years, he has led a multidisciplinary group of academics studying how technology can be used to optimise adherence to therapy and improve outcomes in patients with respiratory disease. He has developed and copyrighted technology related to assessment of inhaler adherence. He holds two patents on the use of audio analysis for respiratory monitoring and estimation of adherence. The INCA technology is licenced to an indigenous Irish company Vitalograph. He has trademarked a FDA-approved process for trage of patients with severe asthma. He has published over 112 original research papers in respiratory medicine. His work is currently supported by grants of over €5m from the EU, industry partners and the Health Research Board of Ireland. He has supervised 15 MD and 10 PhD students. His h-index is 31 with > 3290 citations, and his i10 index is 47. Her major research interest is in the area of pregnancy and diabetes. Her research group is currently conducting a number of studies as part of the ATLANTIC DIP programme. These studies are focusing on pregnancy outcomes in women with type 1 and type 2 diabetes.
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In addition, she is involved in a multicentre Europeanfunded FP7 programme on prevention of gestational diabetes mellitus (DALI) using vitamin D and lifestyle intervention; CONCEPTT, a JDRF-funded programme examining the benefits of CGMS in women with type 1 diabetes during pregnancy; and EVOLVE, a pan European collection of outcomes for women with type 1 and type 2 diabetes treated with insulin.
Professor Dunne is the only Irish committee member of the Diabetes in Pregnancy Study Group (EASD) of EASD and is the President of the International Diabetes in Pregnancy Study Groups (IADPSG) from 2016 to 2021. She is a member of the research committee of the International Federation of Gynecology and Obstetrics (FIGO).
Professor Dunne is actively involved in undergraduate and postgraduate education through the College of Medicine Nursing and Health Sciences at the National University of Ireland, Galway (NUIG) and at the Royal College of Physicians (RCPI).
